Desq Long
Sign in

Company

Eikon Therapeutics, Inc.

EIKN · CIK 0001861123

SEC FORM 4
$1,031,044.96

Eikon Therapeutics, Inc. (EIKN)

Purchase of 89,200 shares at $11.5588 per share.

Reporting Persons Column Group IV GP, LP · Column Group IV-A, LP · Column Group IV, LP · Column Group Opportunity III, LP · Column Group Opportunity III GP, LP · TCG Opportunity III GP, LLC · Kutzkey Tim · Svennilson Peter · Transaction Code P

Traded Sep 3, 2026 · Disclosed Sep 8, 2026

Source: SEC Form 4 · 0001193125-26-385268 · filed 2026-09-08 · View filing →